BACKGROUND: Chronic kidney disease is a progressive disease, which terminates in end-stage renal diseases (ESRD) that requires either dialysis or kidney transplantation for the patient to survive. There is an alarming trend in the disparities of ESRD in African Americans (AAs). Currently, AAs represent more than 30% of incident ESRD cases, yet they constitute 15% of the overall US population. Despite the reductions in mortality, increases in access to patient-centered home dialysis and preemptive kidney transplantation for the overall US ESRD population over the last decade, disparities in the care of AAs with ESRD remain largely unaffected. SUMMARY: This review discusses patient-, community-, and practitioner-related factors that contribute to disparities in ESRD care for AAs. In particular, the review addresses issues related to end-of-life support, the importance of Apolipoprotein-1 gene variants, and the advent of pharmacogenomics toward achieving precision care. The need for accessible clinical intelligence for the ESRD population is discussed. Several interventions and a call to action to address the disparities are presented. Key Messages: Significant disparities in ESRD care exist for AAs. Strategies to enhance patient engagement, education, accountable partnerships, and clinical intelligence may reduce these disparities.
BACKGROUND:Chronic kidney disease is a progressive disease, which terminates in end-stage renal diseases (ESRD) that requires either dialysis or kidney transplantation for the patient to survive. There is an alarming trend in the disparities of ESRD in African Americans (AAs). Currently, AAs represent more than 30% of incident ESRD cases, yet they constitute 15% of the overall US population. Despite the reductions in mortality, increases in access to patient-centered home dialysis and preemptive kidney transplantation for the overall US ESRD population over the last decade, disparities in the care of AAs with ESRD remain largely unaffected. SUMMARY: This review discusses patient-, community-, and practitioner-related factors that contribute to disparities in ESRD care for AAs. In particular, the review addresses issues related to end-of-life support, the importance of Apolipoprotein-1 gene variants, and the advent of pharmacogenomics toward achieving precision care. The need for accessible clinical intelligence for the ESRD population is discussed. Several interventions and a call to action to address the disparities are presented. Key Messages: Significant disparities in ESRD care exist for AAs. Strategies to enhance patient engagement, education, accountable partnerships, and clinical intelligence may reduce these disparities.
Keywords:
Accountable partnerships; African Americans; Call to action; Care coordination; End of life; End-stage renal disease; Health disparities; Palliative care
Authors: Allan J Collins; Robert N Foley; Charles Herzog; Blanche Chavers; David Gilbertson; Areef Ishani; Bertram Kasiske; Jiannong Liu; Lih-Wen Mau; Marshall McBean; Anne Murray; Wendy St Peter; Haifeng Guo; Sally Gustafson; Qi Li; Shuling Li; Suying Li; Yi Peng; Yang Qiu; Tricia Roberts; Melissa Skeans; Jon Snyder; Craig Solid; Changchun Wang; Eric Weinhandl; David Zaun; Cheryl Arko; Shu-Cheng Chen; Frederick Dalleska; Frank Daniels; Stephan Dunning; James Ebben; Eric Frazier; Christopher Hanzlik; Roger Johnson; Daniel Sheets; Xinyue Wang; Beth Forrest; Edward Constantini; Susan Everson; Paul Eggers; Lawrence Agodoa Journal: Am J Kidney Dis Date: 2011-01 Impact factor: 8.860
Authors: Clint Mizzi; Brock Peters; Christina Mitropoulou; Konstantinos Mitropoulos; Theodora Katsila; Misha R Agarwal; Ron H N van Schaik; Radoje Drmanac; Joseph Borg; George P Patrinos Journal: Pharmacogenomics Date: 2014-06 Impact factor: 2.533
Authors: Susanne B Nicholas; Naureen Tareen; Ashraf Zadshir; David Martins; Deyu Pan; Keith C Norris Journal: Kidney Int Suppl Date: 2005-08 Impact factor: 10.545
Authors: Luc Vanhamme; Françoise Paturiaux-Hanocq; Philippe Poelvoorde; Derek P Nolan; Laurence Lins; Jan Van Den Abbeele; Annette Pays; Patricia Tebabi; Huang Van Xong; Alain Jacquet; Nicole Moguilevsky; Marc Dieu; John P Kane; Patrick De Baetselier; Robert Brasseur; Etienne Pays Journal: Nature Date: 2003-03-06 Impact factor: 49.962
Authors: Deidra C Crews; Raquel F Charles; Michele K Evans; Alan B Zonderman; Neil R Powe Journal: Am J Kidney Dis Date: 2010-03-06 Impact factor: 8.860
Authors: Rachel E Patzer; Jennifer Gander; Leighann Sauls; M Ahinee Amamoo; Jenna Krisher; Laura L Mulloy; Eric Gibney; Teri Browne; Laura Plantinga; Stephen O Pastan Journal: BMC Nephrol Date: 2014-10-28 Impact factor: 2.388
Authors: Ladan Golestaneh; Kerri L Cavanaugh; Yungtai Lo; Angelo Karaboyas; Michal L Melamed; Tanya S Johns; Keith C Norris Journal: Am J Kidney Dis Date: 2020-07-13 Impact factor: 8.860
Authors: Shipra Arya; Taylor A Melanson; Elizabeth L George; Kara A Rothenberg; Manjula Kurella Tamura; Rachel E Patzer; Jason M Hockenberry Journal: J Am Soc Nephrol Date: 2020-01-15 Impact factor: 10.121
Authors: Satyesh K Sinha; Susanne B Nicholas; Jung Hye Sung; Adolfo Correa; Tripathi B Rajavashisth; Keith C Norris; Jae Eun Lee Journal: Diabetes Care Date: 2019-09-11 Impact factor: 17.152
Authors: Kunal Sanghavi; W Gregory Feero; Debra J H Mathews; Anya E R Prince; Lori Lyn Price; Edison T Liu; Kyle B Brothers; J Scott Roberts; Charles Lee Journal: Front Genet Date: 2021-03-17 Impact factor: 4.599
Authors: Dina A Tallman; Eno Latifi; Deepinder Kaur; Ayesha Sulaheen; T Alp Ikizler; Karuthan Chinna; Zulfitri Azuan Mat Daud; Tilakavati Karupaiah; Pramod Khosla Journal: Nutrients Date: 2020-03-18 Impact factor: 5.717